Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search
Apr 13 2020

A Brief Additional Note on Immunity and Antibodies

By Kevin Roche Commentary No Comments
A New York Times story focuses on immunity and antibodies.
Read More
Apr 13 2020

When and How Should We Ease Mitigation Measures

By Kevin Roche Commentary No Comments
A study in Lancet recommends caution in relaxing extreme shutdown measures.
Read More
Apr 13 2020

What Comes Next?

By Kevin Roche Commentary One Comment
People are getting antsy about changing the shutdown strategy. We should be realistic about the future course of the epidemic.
Read More
Apr 13 2020

A Few More Observations on Modeling

By Kevin Roche Commentary No Comments
Models of coronavirus spread can be useful; their limitations just have to be understood and well-communicated.
Read More
Apr 12 2020

How to Think About Coronavirus Modeling

By Kevin Roche Commentary No Comments
Here is a chart that may help you think about coronavirus models.
Read More
Apr 12 2020

Sweden

By Kevin Roche Commentary No Comments
Sweden has adopted a more balanced approach to mitigation of spread of the coronavirus.
Read More
Apr 12 2020

More Summaries from Some Interesting Studies

By Kevin Roche Commentary No Comments
It is hard to keep up with all the studies being published on coronavirus. Here are summaries of a couple of the most interesting ones.
Read More
Apr 11 2020

Minnesota Madness

By Kevin Roche Commentary 5 Comments
My home state released information on the models used to justify the shutdown order in the state and there is good and bad news in reviewing the materials. You should…
Read More
Apr 10 2020

Where We Are on Coronavirus

By Kevin Roche Commentary No Comments
Time for another weekly recap of what we do and don't know about coronavirus.
Read More
Apr 10 2020

We Need Antibody Testing Now!!

By Kevin Roche Commentary No Comments
This can't be said any more clearly and strongly: we need widespread antibody testing now.
Read More
Apr 10 2020

The Way We Live Now

By Kevin Roche Commentary One Comment
We can't let this shutdown fundamentally change how we relate to one another.
Read More
Apr 10 2020

Some CDC and Other Stats of Interest

By Kevin Roche Commentary No Comments
A quick look at some stats of interest on coronavirus.
Read More
Apr 09 2020

Yet More Coronavirus Research

By Kevin Roche Commentary No Comments
Some more interesting research on transmission of the coronavirus.
Read More
Apr 09 2020

Just in Case You Don’t Think We Are Completely Destroying the Economy and Jobs

By Kevin Roche Commentary No Comments
The numbers on economic damage are astounding.
Read More
Apr 09 2020

New Paper On Death Risk

By Kevin Roche Commentary No Comments
A hot-off-the-presses paper analyzes death risk from coronavirus disease.
Read More
  • Previous
  • 1
  • …
  • 236
  • 237
  • 238
  • 239
  • 240
  • …
  • 429
  • Next

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

IKS Health, a British company with a US subsidiary that offers “care enablement” and mentions AI, of course,  is buying TruBridge for $557 million.  TruBridge offers revenue cycle management and...
April 30, 2026
Innovacer, which basically collects data on a patient from multiple sources and aggregates it, raised an astounding $275 million in new capital, supposedly at a valuation of almost $3.5 billion....
April 22, 2026
A company called Whoop raised a ridiculous $575 million in new capital at a supposed $10 billion valuation.  The press release was released on April 1, so I would like...
April 5, 2026
Big deals continue in health care financings.  eMed, which manages weight loss medications for employers, raises a hefty $200 million, giving it a valuation of $2 billion, which seems crazy....
March 31, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1844) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Congressional Budget Office
  • Health Affairs

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts